FINWIRES · TerminalLIVE
FINWIRES

Campbell's Could See Challenging Fiscal 2027 Amid Inflation, Pricing Pressures, UBS Says

By

Campbell's (CPB) could see a challenging fiscal 2027 due to pressures related to inflation, pricing, and continued marketing investments, among others, UBS Securities said in a Monday note.

Campbell's has also flagged headwinds from incentive compensation resent and a higher share count, UBS noted.

The company reported fiscal Q3 adjusted earnings of $0.50 per diluted share, down from $0.73 a year earlier, as net sales declined to $2.37 billion from $2.48 billion. And there are but "little signs that a return to EPS growth is on the horizon" for the company, UBS said.

For fiscal 2026, Campbell's reiterated its adjusted EPS outlook of $2.15 to $2.25 and a 1% to 2% decline in organic sales. The top-line outlook appears "somewhat aspirational" and top-line growth in fiscal 2027 seems "unlikely," the brokerage said.

UBS cut its price target on Campbell's to $17 from $19, with a sell rating.

Price: $21.93, Change: $+0.44, Percent Change: +2.05%

Related Articles

Wire

Mission Produce Fiscal Q2 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Mission Produce (AVO) reported fiscal Q2 non-GAAP net income late Monday of $0.01 per diluted share, down from $0.12 a year earlier.Three analysts polled by FactSet expected $0.05.Revenue in the three months ended April 30 fell to $290.9 million from $380.3 million a year earlier.Three analysts expected $256.3 million.The board approved a stock repurchase program of up to $100 million over the next 36 months.The company's shares fell 5.9% in after-hours trading.

$AVO
Wire

Mama's Creations Fiscal Q1 Earnings, Revenue Rise

Mama's Creations (MAMA) reported fiscal Q1 earnings late Monday of $0.05 per diluted share, up from $0.03 a year earlier.Analysts polled by FactSet expected $0.03.Revenue in the three months ended April 30 rose to $52.8 million from $35.3 million a year earlier.Analysts expected $51.6 million.The company's shares fell 2.6% in after-hours trading.

$MAMA
Wire

Tango Therapeutics Launches $500 Million Stock Offering

Tango Therapeutics (TNGX) said Monday it is launching $500 million underwritten public offering of common stock.All shares are offered by the company, according to a statement.Tango said it will grant underwriters a 30-day option to purchase up to an additional $75 million of shares.

$TNGX